NCT03016494

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

A Randomized, Open-label, Oral Dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of Fixed-dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the safety and pharmacokinetics between co-administration and fixed dose combination of DWC20155 and DWC20156 in healthy subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Co-administration of DWC20155 and DWC20156
DRUG	DWJ1386 Tab.

Timeline

• Start date: 2016-02-01
• Primary completion: 2017-03-01
• First posted: 2017-01-10
• Last updated: 2017-01-10

Locations

1 site across 1 country: South Korea